Novel Approach Strips Staph of Virulence
NIH, National Institute of General Medical Sciences (NIGMS)An international team of researchers supported by the National Institutes of Health has blocked staph infections in mice using a drug previously tested in clinical trials as a cholesterol-lowering agent. The novel approach, described in the February 14 online edition of Science, could offer a new direction for therapies against a bacterium that's becoming increasingly resistant to antibiotics.